EBS SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 2, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Apr 30, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 26, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 29, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Emergent BioSolutions Receives $22.3 Million Delivery Order Modification to Supply BioThrax to the U.S. Department of War

Nov 4, 2026

8-K

Emergent BioSolutions Reports Third Quarter 2026 Financial Results

Nov 2, 2026

8-K

Emergent BioSolutions Announces CFO Retirement and Interim Appointment

Oct 16, 2026

8-K

Emergent BioSolutions Highlights Multi-Year Transformation Plan and Biodefense Portfolio at H.C. Wainwright Conference

Sep 14, 2026

8-K

Emergent BioSolutions Awarded $24 Million Contract Modification for CYFENDUS® Anthrax Vaccine

Sep 1, 2026

8-K

Emergent BioSolutions Reports Second Quarter 2026 Financial Results and Announces Organizational Restructuring

Aug 5, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 3,613,338 | Warrants amount: 2,500,000 | Warrants exercise price: $12.80

Mar 24, 2025

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Mar 4, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 3,613,338 | Warrants amount: 2,500,000 | Warrants exercise price: $12.80

Dec 4, 2024

424B5

ATM | Offering amount: $150,000,000

May 18, 2023

425

Registration

Oct 21, 2010

425

Registration

Oct 8, 2010

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Apr 30, 2026

S-3

August 2025 SHELF EFFECTIVE, DATED 2025-08-15

Aug 7, 2025

POS AM

Form POS AM - Post-Effective amendments for registration statement

Mar 4, 2025

POS EX

Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]

Mar 4, 2025

S-1/A

SHARE RESALE REGISTRATION | Shares amount: 3,613,338 | Warrants amount: 2,500,000 | Warrants exercise price: $9.88 EFFECTIVE

Dec 2, 2024

S-1

SHARE RESALE REGISTRATION | Shares amount: 3,613,338 | Warrants amount: 2,500,000 | Warrants exercise price: $9.88 EFFECTIVE

Nov 12, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A